North Manchester General Hospital (NMGH) is a large NHS hospital in Crumpsall in the north of the English city of Manchester. It is operated by Manchester University NHS Foundation Trust on behalf of the Northern Care Alliance NHS Group. There is an accident and emergency unit, together with a maternity unit, high dependency unit and a mental health wing. A long-awaited plan to rebuild the hospital was announced publicly by Boris Johnson in the 2019 General Election campaign, and in November 2020 a £54 million funding bid for improvement works was made by the Trust, the city council and Manchester Health and Care Commissioning.
Introduction Asymptomatic physiological hypercalcaemia in exclusively breastfed infants is recognised but has not been systematically characterised when breastfeeding is continued.Objective To evaluate the clinical, biochemical and radiological outcomes of breast milk–associated physiological hypercalcaemia.Methods A multi-centre retrospective study over 5 years included infants with hypercalcaemia (serum corrected calcium (cCa) ≥2.8 mmol/L) who were exclusively breastfed and had no other identifiable causes of hypercalcaemia. Clinical, biochemical and radiological data were analysed.Results Twenty-five infants (15 males, 10 females) were studied. The mean peak cCa was 3.08 mmol/L (SD 0.17; normal 2.2–2.8 mmol/L). All infants were asymptomatic and continued exclusive breastfeeding without interventions such as intravenous fluids, diuretics or bisphosphonates. Mean serum parathyroid hormone (PTH) was suppressed at 1.04 pmol/L (SD 0.9; reference 2.0–9.4 pmol/L). Renal ultrasound examinations performed in all infants showed no nephrocalcinosis. Hypercalcaemia resolved spontaneously over a median of 64 (range, 9–329) days, and the median duration of exclusive breastfeeding was 150 (range, 8–540) days.Conclusion Breast milk–associated physiological hypercalcaemia is a benign, PTH-independent condition without clinical symptoms or nephrocalcinosis. Infants can safely continue exclusive breastfeeding, preserving its well-established benefits, without switching to low calcium formulas. Further research is needed to elucidate the underlying mechanisms.
Pyometra is an uncommon uterine infection that predominantly affects postmenopausal females. It can present with non-specific features and may at times mimic gastrointestinal pathology, delaying diagnosis. An 81-year-old female with multiple comorbidities and frailty presented to the emergency department with two weeks of poor oral intake and reduced mobility. She was treated as having sepsis of unclear source with suspected respiratory infection. Despite broad-spectrum intravenous antibiotics, she deteriorated clinically with persistently raised inflammatory markers. She developed abdominal discomfort, constipation, and then abdominal distension and right-sided abdominal tenderness. An abdominal X-ray showed dilated bowel loops on the right. Pelvic magnetic resonance imaging (MRI) demonstrated a markedly distended uterine cavity containing a large fluid collection with an air-fluid level and restricted diffusion, consistent with pyometra. Malignancy could not be excluded on imaging. The case was discussed with gynaecology and microbiology, and antibiotics were escalated. A best interests meeting concluded that definitive management with uterine drainage was too invasive given her frailty and unlikely tolerance. She was managed conservatively with intravenous antibiotics, with transient improvement in delirium and inflammatory markers. This case highlights pyometra as an important differential diagnosis in elderly women presenting with abdominal symptoms and bowel dilatation on imaging. Early pelvic imaging should be considered when sepsis persists without a clear source.
Colorectal neoplasia contributes substantially to the global burden of disease, and selecting the most appropriate endoscopic treatment is essential to reduce recurrence and avoid surgery. This systematic review focused exclusively on direct comparisons of endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) for colorectal neoplasia while excluding non-colorectal lesions, single-arm studies, rectal neuroendocrine tumors, and other non-comparable interventions (studies without direct EMR versus ESD comparison). A systematic search of PubMed, Embase, and Scopus from inception to June 2025 was performed in accordance with the PRISMA guidelines. Six reviewers independently screened studies, and 17 comparative studies involving 3790 lesions were included. Data were extracted for tumor size, procedure time, en bloc resection, complete RO resection, recurrence, and major complications, including perforation and delayed bleeding. Risk of bias was assessed using the Newcastle-Ottawa Scale for observational studies and the Cochrane Risk of Bias 2 (RoB 2) tool for randomized trials. Across included studies, ESD was used for larger lesions, required longer procedure times, and achieved higher en bloc and R0 resection rates than EMR. ESD also demonstrated lower recurrence, whereas perforation and delayed bleeding were generally more frequent after ESD. EMR remained faster and was associated with a lower perforation risk, particularly in smaller and less complex lesions. Overall, ESD provides superior oncologic resection quality and lower recurrence but at the cost of greater technical burden and a higher complication profile.